...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Researchers Successfully Treat Metastatic Cancer

Nice to hear from you LongRVXer. Yes, this has been discussed before when the study was first published at beginning of September, news released by Zenith, and discussed at the AGM. Good stuff.

Share
New Message
Please login to post a reply